Peptide profile

Thymopentin

Also known as TP-5

Thymopoietin-derived pentapeptide studied in immune signaling

Clinical research
Editorial laboratory imageryScience, with its context intact.
What to know

The evidence
in perspective.

A small randomized trial evaluated adjunctive treatment for severe atopic dermatitis. Historical, disease-specific evidence does not establish routine immune enhancement or the suitability of a compounded preparation.

View the supporting source
Research area
Immune
Biological target or mechanism
Thymopoietin-derived pentapeptide studied in immune signaling
Evidence context
Clinical research
Availability
Availability requires pharmacy review
From information to a conversation

Clinical decisions stay
with clinical professionals.

This profile is a research reference. Your prescriber and pharmacy assess the relevant clinical and dispensing pathway. Inclusion here is not an offer to sell this compound.

Start a conversation

Find your lane.

Tell us about your business and what you want to explore.

Review your details before sending. Please do not include patient information.